1-7 of 7
Satoshi Matsusaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection

Stefan Stremitzer, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Satoshi Matsusaka, Anish Parekh, Satoshi Okazaki, Diana Hanna, Stephanie H. Astrow, Miriana Moran, Jose Hernandez, Craig Stephens, Stefan J. Scherer, Judith Stift, Friedrich Wrba, Thomas Gruenberger, Heinz-Josef Lenz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (11): 2814–2821.
https://doi.org/10.1158/1535-7163.MCT-16-0275
Published: 01 November 2016
View articletitled, Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Open the PDF for Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection in another window
Includes: Supplementary data
Journal Articles

Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab

Satoshi Okazaki, Fotios Loupakis, Sebastian Stintzing, Shu Cao, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Stefan Stremitzer, Satoshi Matsusaka, Martin D. Berger, Anish Parekh, Jordan D. West, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Chiara Cremolini, Alfredo Falcone, Volker Heinemann, R. William DePaolo, Heinz-Josef Lenz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (7): 1740–1745.
https://doi.org/10.1158/1535-7163.MCT-15-0931
Published: 05 July 2016
View articletitled, Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab
Open the PDF for Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab in another window
Includes: Supplementary data
Journal Articles

TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy

Satoshi Matsusaka, Wu Zhang, Shu Cao, Diana L. Hanna, Yu Sunakawa, Ana Sebio, Masashi Ueno, Dongyun Yang, Yan Ning, Anish Parekh, Satoshi Okazaki, Martin D. Berger, Wataru Ichikawa, Nobuyuki Mizunuma, Heinz-Josef Lenz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (6): 1405–1411.
https://doi.org/10.1158/1535-7163.MCT-15-0751
Published: 02 June 2016
View articletitled, TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy
Open the PDF for TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer

Sebastian Stintzing, Wu Zhang, Volker Heinemann, Daniel Neureiter, Ralf Kemmerling, Thomas Kirchner, Andreas Jung, Matthias Folwaczny, Dongyun Yang, Yan Ning, Ana Sebio, Stefan Stremitzer, Yu Sunakawa, Satoshi Matsusaka, Shinichi Yamauchi, Fotios Loupakis, Chiara Cremolini, Alfredo Falcone, Heinz-Josef Lenz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (10): 2374–2381.
https://doi.org/10.1158/1535-7163.MCT-15-0121
Published: 05 October 2015
View articletitled, Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer
Open the PDF for Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach

Yan Ning, Diana L. Hanna, Wu Zhang, Angela Mendez, Dongyun Yang, Rita El-Khoueiry, Satoshi Matsusaka, Yu Sunakawa, Stefan Stremitzer, Anish Parekh, Satoshi Okazaki, Martin D. Berger, Afsaneh Barzi, Heinz-Josef Lenz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (10): 2401–2408.
https://doi.org/10.1158/1535-7163.MCT-15-0359
Published: 05 October 2015
View articletitled, Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach
Open the PDF for Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach in another window
Includes: Supplementary data
Journal Articles

Abstract A183: Ex vivo imaging of EGF receptor‐mediated signal transduction for prediction of anti‐EGFR treatment efficacy

Yuji Mishima, Satoshi Matsusaka, Yasuhito Terui, Yuko Matsumoto Mishima, Ryoko Kuniyoshi, Kiyohiko Hatake
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A183.
https://doi.org/10.1158/1535-7163.TARG-09-A183
Published: 10 December 2009
View articletitled, Abstract A183: Ex vivo imaging of EGF receptor‐mediated signal transduction for prediction of anti‐EGFR treatment efficacy
Journal Articles

Abstract B68: Ubiquitin E3 ligase, tripartite motif protein 68 (TRIM68) inhibits TCP‐1β function and can be a target of imatinib‐resistance

Ryoko Kuniyoshi, Yasuhito Terui, Yuji Mishima, Satoshi Matsusaka, Kiyohiko Hatake
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B68.
https://doi.org/10.1158/1535-7163.TARG-09-B68
Published: 10 December 2009
View articletitled, Abstract B68: Ubiquitin E3 ligase, tripartite motif protein 68 (TRIM68) inhibits TCP‐1β function and can be a target of imatinib‐resistance